Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Jul 27
 -7.22 / -1.40%
Today’s Change
Today|||52-Week Range
Ophthotech (OPHT) Q2 Loss Narrows, Focus Shifts to Zimura
Jul 27 / Zacks.com - Paid Partner Content
Fears over a medical gold rush in cancer drug race
Jul 02 / FT.com - Paid Partner Content
Can Regeneron Pharma (REGN) Pull a Surprise in Q2 Earnings?
Jul 26 / Zacks.com - Paid Partner Content